IL6 and Parkinson disease: An indication that the immune system is responding to tissue damage stems from increased TNF-α, IL-1β, IL-2, IL-6, IFN-γ, and CCL2 levels observed in the blood and cerebrospinal fluid (CSF) of PD patients (88–91).